re: re:sirtex and positive american exposure In context to new shareholders I trust Hunter hall, Dr Gray, Macquarie, and Sirtex product and growth of company due to Nat Geissel CEO of Sirtex USA alot more than any others and they will deliver to new and old shareholders the value we deserve. At 4x 2008 earnings with excellent balance sheet,and 11 % of capitalization in cash this is the most undervalued highest growth potential Australian biotech company on the ASX and the next acquisition target as health sector consolidation continues.My opinion only after being in the industry along time . do your own work
latest news, page-47
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $292.8K | 1.630M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7394560 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1260654 | 10 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |